DORCHESTER WEALTH MANAGEMENT Co Grows Holdings in Kenvue Inc. (NYSE:KVUE)

DORCHESTER WEALTH MANAGEMENT Co boosted its holdings in Kenvue Inc. (NYSE:KVUE) by 8.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 347,270 shares of the company’s stock after purchasing an additional 25,650 shares during the quarter. Kenvue comprises 1.4% of DORCHESTER WEALTH MANAGEMENT Co’s investment portfolio, making the stock its 29th largest holding. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Kenvue were worth $8,032,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Manchester Capital Management LLC grew its stake in shares of Kenvue by 80.8% during the 1st quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock worth $25,000 after purchasing an additional 530 shares during the period. Mather Group LLC. acquired a new position in shares of Kenvue during the 1st quarter worth $28,000. Riverview Trust Co acquired a new stake in Kenvue in the 3rd quarter valued at about $30,000. MV Capital Management Inc. grew its stake in Kenvue by 71.2% in the 1st quarter. MV Capital Management Inc. now owns 1,544 shares of the company’s stock valued at $33,000 after acquiring an additional 642 shares during the last quarter. Finally, Salomon & Ludwin LLC acquired a new stake in Kenvue in the 1st quarter valued at about $33,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

KVUE has been the topic of a number of research reports. UBS Group increased their price objective on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Citigroup cut their price objective on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. Piper Sandler increased their price objective on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Monday, September 23rd. Royal Bank of Canada lowered shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective on the stock. in a report on Tuesday, September 24th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $22.64.

Kenvue Stock Up 0.4 %

NYSE:KVUE traded up $0.09 during trading hours on Thursday, hitting $22.85. The stock had a trading volume of 693,731 shares, compared to its average volume of 18,110,135. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.69. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $23.55. The business has a 50 day simple moving average of $22.36 and a two-hundred day simple moving average of $20.26. The company has a market cap of $43.75 billion, a PE ratio of 29.17, a price-to-earnings-growth ratio of 2.76 and a beta of 1.40.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.04. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The company had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. During the same quarter last year, the company earned $0.32 earnings per share. Kenvue’s revenue for the quarter was down .3% on a year-over-year basis. Analysts predict that Kenvue Inc. will post 1.08 EPS for the current year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be paid a $0.205 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.59%. Kenvue’s dividend payout ratio (DPR) is presently 105.13%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.